45
Opioid Prescribing for Chronic Non-Cancer Pain: Weighing the Benefits & Risks Paul C. Coelho, MD Board Certified PM&R Subspecialty Certified Pain Medicine

Opioid patienttalk1

  • Upload
    101n

  • View
    480

  • Download
    5

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Opioid patienttalk1

Opioid Prescribing for Chronic Non-Cancer Pain: Weighing the Benefits &

Risks Paul C. Coelho, MD

Board Certified PM&R Subspecialty Certified Pain Medicine

Presenter
Presentation Notes
Paul C. Coelho, MD Board Certified Physical Medicine & Rehabiliation Subspecialty Certified in Pain Medicine Disclosures: None
Page 2: Opioid patienttalk1

Table Of Contents

1. Patient Expectations for Pain Relief with Opioids

2. Actual Pain Relief with Opioids 3. Risks of Opioids for Chronic Noncancer Pain 4. Risk Reduction Opioid Clinic

Page 3: Opioid patienttalk1

1. Opioids: Realistic Benefits

Page 4: Opioid patienttalk1

Patients Often Expect 75% for Pain Relief with Opioids

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed?cmd=historysearch&querykey=23
Page 5: Opioid patienttalk1

Expectation

75% Pain Relief

Page 6: Opioid patienttalk1

2. Opioids: Actual Pain Relief

Page 7: Opioid patienttalk1

Actual Pain Relief with Opioids for Chronic Non-

Cancer Pain is about 30%

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed/15561393
Page 8: Opioid patienttalk1

Actual Pain Relief

Is More Modest about 30%

Page 9: Opioid patienttalk1

Expectation (75%) vs Reality (30%)

Patient Expectation

Medical Reality

Page 10: Opioid patienttalk1

Rising Opioid Overdose Visits in the ER

Page 11: Opioid patienttalk1

Medicine Alone Does Not Work Well for Chronic Pain

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed/?term=Expect+Anagesic+failure%3A+pursue+analgesic
Page 12: Opioid patienttalk1

Pain Specialists Consider 30% Relief a Success

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical+Importanc+of+chronic+pain+intensity+measured+on+an+11-point
Page 13: Opioid patienttalk1

Pain Specialists Also Use Other Objective Measures

of Pain Relief

• Improved Sleep • Decreased Depression • Improved Fatigue • Improved Function • Return to Work

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed/?term=Expect+Anagesic+failure%3A+pursue+analgesic
Page 14: Opioid patienttalk1

Pain Specialists Also Use Other Therapies for Pain

• Activity Modifications • Life-Style Changes:

• Weight-loss • Smoking Cessation • Aerobic Activity

• Physical Therapy • Treatment of Depression

• Treatment of Anxiety • Treatment of PTSD • Cognitive Behavioral Therapy • Treatment of

Addiction/Dependency • Injections • Surgery

Page 15: Opioid patienttalk1

3. Opioids: Real Risks

Page 16: Opioid patienttalk1

Common Opioid Side-Effects

Breathing Problems Nausea Heart Attacks Dizziness Falls Worsening Pain Fractures

Decreased Sex Drive Immunosupression Dependency Addiction Overdose

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed/23106029
Page 17: Opioid patienttalk1

Oregon Ranks #1 in the Nation in Prescription

Opioid Abuse

Presenter
Presentation Notes
6. http://www.samhsa.gov/data/2k12/NSDUH115/sr115-nonmedical-use-pain-relievers.htm
Page 18: Opioid patienttalk1

Prescription Opioid Deaths In Oregon 2000-2011

Presenter
Presentation Notes
7. http://public.health.oregon.gov/DiseasesConditions/InjuryFatalityData/Documents/NGA-overdose-presentation_Millet_12-05-2012.pdf
Page 19: Opioid patienttalk1

Women Are Disproportionately Affected

By Overdose Deaths

Presenter
Presentation Notes
http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/
Page 20: Opioid patienttalk1

More than 50% of patients receiving opioids for 90d will remain on opioids for years.

Presenter
Presentation Notes
6. http://www.ncbi.nlm.nih.gov/pubmed/21751058
Page 21: Opioid patienttalk1

High Dose Opioids Use Is Associated with Addiction &

Depression

Page 22: Opioid patienttalk1

1/3rd Of Patients Treated in Addiction Clinics Come

From Pain Clinics

Presenter
Presentation Notes
5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129653/
Page 23: Opioid patienttalk1

Prescription Opioid Deaths & Addiction Treatment

Parallel Opioid Prescribing

Presenter
Presentation Notes
8. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm
Page 24: Opioid patienttalk1

4. Opioids: Risk Reduction

Page 25: Opioid patienttalk1

Who Can Not Be Treated With Opioids

1. Any history of diversion (selling drugs) 2. A history of suicide attempts with medication 3. Current methadone maintenance (addiction treatment) 4. No functional improvement after a trial or chronic use of opioids 5. A history of misuse or over use as defined by multiple prescriptions from multiple different providers or sites (doctor shopping) 6. A history of frequent utilization of the emergency room for attaining opioids 7. Prior dismissal violation of an opioid agreement 8. Active substance abuse, including alcohol, in the past 12 months 9. The use of marijuana, regardless of authorization status 10. Untreated or undertreated mental health condition 11. Opioid risk score > 7

Presenter
Presentation Notes
http://www.lcmedsociety.com/files/static_page_files/BE1728DE-C29E-0B97-09F765ADA4872D25/LCMS%20NL%202012%2003%20March.pdf
Page 26: Opioid patienttalk1

Minimize Opioid Use In Conditions For Which There Is No Objective

Marker Of Disease Chronic LBP Fibromyalgia Syndrome Chronic HA Chronic Abdominal Pain Chronic Pelvic Pain Phantom Limb Pain

Page 27: Opioid patienttalk1

Stratify Patients for Risk of Abuse

Presenter
Presentation Notes
11. http://www.partnersagainstpain.com/printouts/Opioid_Risk_Tool.pdf Refer high risk patients - > 7 -for a pain management consultation.
Page 28: Opioid patienttalk1

Adopt WA State Dosing Guidelines

1. Low Dose = <50 MED

2. Intermediate Dose = 50 -100MED

3. High Dose = > 100MED

Milligrams Equivalent Dose (MS04)

Presenter
Presentation Notes
12. http://www.ncbi.nlm.nih.gov/pubmed/20083827� http://www.ncbi.nlm.nih.gov/pubmed/21467284� http://www.ncbi.nlm.nih.gov/pubmed/21482846��http://www.ncbi.nlm.nih.gov/pubmed/22026451��http://www.fda.gov/downloads/Drugs/N.../UCM307844.pdf Dosages in excess of 100MED/day warrant a pain management consultation. MED = Milligrams Equivalent Dose (Morphine)
Page 29: Opioid patienttalk1

Examples of 100MED

MSContin 30mg TID Oxycontin 30mg po BID Fentanyl Patch 25mcg/72hrs Opana 20mg po BID Nucynta 150mg po BID *Methadone 15mg po BID

Presenter
Presentation Notes
Not Recommended.
Page 30: Opioid patienttalk1

Limiting Opioids Dose for Non-Cancer Pain Saves

Lives

Presenter
Presentation Notes
13. http://www.doh.wa.gov/Newsroom/2013NewsReleases/13006PrescriptionDrugDeathsDrop.aspx
Page 31: Opioid patienttalk1

Limiting Opioids Dose for Non-Cancer Pain Saves

Lives

Presenter
Presentation Notes
14. http://www.ncbi.nlm.nih.gov/pubmed/22213274
Page 32: Opioid patienttalk1

Avoid Methadone

Presenter
Presentation Notes
15. http://oregonrxsummit.org/rx_discussion/prescription-drug-abuse-a-public-health-perspective/
Page 33: Opioid patienttalk1

Avoid Methadone

Presenter
Presentation Notes
16.http://www.oregon.gov/oha/pharmacy/DocumentsArticlesPublications/Prescription%20opioid%20overdose%20and%20misuse%20in%20Oregon%20presentation.pptx
Page 34: Opioid patienttalk1

Avoid Benzodiazepines : Valium, Xanax, Soma

Presenter
Presentation Notes
17. http://www.ncbi.nlm.nih.gov/pubmed/23423407
Page 35: Opioid patienttalk1

Prescribe Rescue Medications & Training To

Special Populations

Presenter
Presentation Notes
1. http://www.ncbi.nlm.nih.gov/pubmed/21668761 2. Needle-less Naloxone: http://www.ims-limited.com/images/Naloxone.pdf�3. Nasal atomizer: http://www.lmana.com/pwpcontrol.php?pwpID=6359
Page 36: Opioid patienttalk1

Set Reasonable Expectations For

Treatment: 30% Relief

Presenter
Presentation Notes
http://www.ncbi.nlm.nih.gov/pubmed/?term=opioids+in+chronic+non-cancer+pain+a+systematic+reivew+of+safety+and+efficacy+and+kalso
Page 37: Opioid patienttalk1

Utilize a Formal Treatment Agreement

Presenter
Presentation Notes
20. http://www.oregon.gov/omb/newsletter/winter2011.pdf
Page 38: Opioid patienttalk1

Document Adverse Effects

Adverse Effects: 1. Constipation 2. Somnolence 3. SOB 4. Falls 5. Automobile Accidents 6. ER Visits 7. DUI’s

Page 39: Opioid patienttalk1

Document Improvement in Function/Activities

Activities: 1. Exercise 2. Playing with kids/grand kids 3. Travel 4. Household chores 5. Socializing 6. Return to work

Page 40: Opioid patienttalk1

Document Aberrant Behaviors

1. Forging, altering, or stealing prescriptions 2. Stealing, borrowing, trading, buying, or selling drugs 3. Injecting or snorting oral drugs or fentanyl/suboxone patches 4. Doctor shopping/ER visits for opioids 5. Concurrent abuse of alcohol or illicit drugs 6. Falls, accidents, or other sedation related consequences of opioid overuse 7. Frequent stolen or lost prescriptions 8. Resisting changes to medications in spite of adverse effects 9. Aggressively complaining about the need for more drugs 10. Drug hoarding 11. Unsanctioned drug escalations 12. DUI’s 13. Frequent calls to the office to request more medications or early refills 14. Requesting specific drugs by name 15. Multiple reported NSAID or opioid allergies/sensitivities 16. Clinical ambushes with aggressive, hovering family members arguing for dose escalations 17. Marijuana use regardless of authorization status 18. Refusing random urine , blood, or saliva toxicology tests 19. Refusing or ‘no-showing’ for random pill counts

Page 41: Opioid patienttalk1

Aberrant Behaviors Lead to Stopping Prescribing

1.Repeated aberrant behaviors necessitate stopping the opioid trial.

2.The Oregon Medical Board considers patients whose aberrant behavior lead to a dismissal violation with one doctor to be unsuitable for opioid treatment with another doctor.

Presenter
Presentation Notes
http://www.lcmedsociety.com/files/static_page_files/BE1728DE-C29E-0B97-09F765ADA4872D25/LCMS%20NL%202012%2003%20March.pdf
Page 42: Opioid patienttalk1

Access the Prescription Drug Monitoring Program

With Each Visit

Page 43: Opioid patienttalk1

Acquire Random Urine Toxicology Screening

Page 44: Opioid patienttalk1

Schedule a Minimum of Quarterly Follow-Up

Presenter
Presentation Notes
24. http://www.deadiversion.usdoj.gov/fed_regs/rules/2006/fr0906.htm
Page 45: Opioid patienttalk1

Physicians For Responsible Opioid

Prescribing

www.supportprop.org

Presenter
Presentation Notes
Physicians for responsible opioid prescribing. An excellent resource for responsible opioid prescribing.